Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05560477 · ClinicalTrials.gov registry record · Phase 1

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

A Phase 1 study of Meniscus Tear, sponsored by University of Cincinnati.

Recruiting
Registry status
Phase 1
Development phase
74
Enrollment target
3
Study locations

NCT05560477 is a Phase 1 study of Meniscus Tear that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 74 participants, below the 82-participant average among 6 other Meniscus Tear trials with a reported enrollment target (10% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05560477, a Phase 1 study of Meniscus Tear, is actively recruiting participants, sponsored by University of Cincinnati.

RECRUITING
Registry status
Phase 1
Development phase
74 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this clinical trial is to assess the safety and efficacy of AM3101 to facilitate meniscal repair and reduce the incidence of non-healing complications and morbidities associated with a failed meniscal repair. This is a prospective, randomized, controlled, double-blinded, multi-center study.

Conditions Studied

Meniscus Tear

Interventions

  • DRUG AM3101
  • DRUG Saline Placebo

Study Locations (3)

Ohio

  • University of Cincinnati - Cincinnati
  • University Hospitals Cleveland Medical Center - Cleveland

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2023-04-26
Est. Completion 2027-06
Phase Phase 1

Sponsor

University of Cincinnati

245 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05560477

The ClinicalTrials.gov registry entry for NCT05560477 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 6 other Meniscus Tear trials with a reported enrollment target (10% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Meniscus Tear appearing as the primary indexed condition, and to 2 interventions - of which AM3101 is the first listed.

NCT05560477 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Oregon.

Frequently Asked Questions

What is clinical trial NCT05560477 about?

NCT05560477 is a clinical study titled "Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing". The purpose of this clinical trial is to assess the safety and efficacy of AM3101 to facilitate meniscal repair and reduce the incidence of non-healing complications and morbidities associated with a failed meniscal repair. This is a prospective, randomized, controlled, double-blinded, multi-center ...

What is the current status of trial NCT05560477?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2023-04-26. Estimated completion is 2027-06.

What conditions does trial NCT05560477 study?

This clinical trial studies the following conditions: Meniscus Tear.

What interventions are being tested in trial NCT05560477?

The interventions under investigation include: AM3101 (DRUG), Saline Placebo (DRUG).

Who is sponsoring clinical trial NCT05560477?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05560477 being conducted?

This trial has 3 study locations across Ohio, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Meniscus Tear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Meniscus Tear

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.